Companies / Germany
Price War And Consolidation Looms For German Generic Firms
June 2006 | Market Trend AnalysisGeneric drug manufacturers in Germany are set for a price war and consolidation among smaller firms, after three big players cut their prices ahead of healthcare reforms that will reward the use of cheaper pharmaceuticals.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
